NCT02389517 2026-01-22Lenalidomide With or Without Ixazomib Citrate and Dexamethasone in Treating Patients With Residual Multiple Myeloma After Donor Stem Cell TransplantUniversity of ChicagoPhase 2 Completed42 enrolled 11 charts
NCT04991103 2025-12-31Minimal Residual Disease Response-adapted Deferral of Transplant in Dysproteinemia (MILESTONE)University of Alabama at BirminghamPhase 2 Recruiting40 enrolled
NCT03863184 2025-06-06Acalabrutinib-Lenalidomide-Rituximab in Patients With Untreated MCLWeill Medical College of Cornell UniversityPhase 2 Active not recruiting37 enrolled 9 charts